These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23302949)

  • 21. Arrestins in the cardiovascular system.
    Lymperopoulos A; Bathgate A
    Prog Mol Biol Transl Sci; 2013; 118():297-334. PubMed ID: 23764059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-arrestin goes nuclear.
    Beaulieu JM; Caron MG
    Cell; 2005 Dec; 123(5):755-7. PubMed ID: 16325568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular scaffolds regulate bidirectional crosstalk between Wnt and classical seven-transmembrane-domain receptor signaling pathways.
    Force T; Woulfe K; Koch WJ; Kerkelä R
    Sci STKE; 2007 Jul; 2007(397):pe41. PubMed ID: 17666710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms underlying beta-arrestin-dependent chemotaxis and actin-cytoskeletal reorganization.
    McGovern KW; DeFea KA
    Handb Exp Pharmacol; 2014; 219():341-59. PubMed ID: 24292838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions.
    Lee MH; Appleton KM; Strungs EG; Kwon JY; Morinelli TA; Peterson YK; Laporte SA; Luttrell LM
    Nature; 2016 Mar; 531(7596):665-8. PubMed ID: 27007854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring interactions between G-protein-coupled receptors and beta-arrestins.
    Pfleger KD; Dalrymple MB; Dromey JR; Eidne KA
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):764-6. PubMed ID: 17635143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-arrestin signaling and regulation of transcription.
    Ma L; Pei G
    J Cell Sci; 2007 Jan; 120(Pt 2):213-8. PubMed ID: 17215450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressants, beta-arrestins and GRKs: from regulation of signal desensitization to intracellular multifunctional adaptor functions.
    Golan M; Schreiber G; Avissar S
    Curr Pharm Des; 2009; 15(14):1699-708. PubMed ID: 19442183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins.
    Chen W; Hu LA; Semenov MV; Yanagawa S; Kikuchi A; Lefkowitz RJ; Miller WE
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14889-94. PubMed ID: 11742073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling.
    Shenoy SK; Lefkowitz RJ
    Biochem J; 2003 Nov; 375(Pt 3):503-15. PubMed ID: 12959637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell signaling. Beta-arrestin, a two-fisted terminator.
    Grady EF
    Science; 2007 Feb; 315(5812):605-6. PubMed ID: 17272707
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell signaling. beta-arrestin--not just for G protein-coupled receptors.
    Spiegel A
    Science; 2003 Sep; 301(5638):1338-9. PubMed ID: 12958351
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
    Lymperopoulos A
    Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potential novel strategy to separate therapeutic- and side-effects that are mediated via the same receptor: beta-arrestin2/G-protein coupling antagonists.
    Bruns IR; Chhum S; Dinh AT; Doerr H; Dunn NR; Ly YT; Mitman CL; Rickards HD; Sol C; Wan EW; Raffa RB
    J Clin Pharm Ther; 2006 Apr; 31(2):119-28. PubMed ID: 16635045
    [No Abstract]   [Full Text] [Related]  

  • 36. Biased signaling through G-protein-coupled PROKR2 receptors harboring missense mutations.
    Sbai O; Monnier C; Dodé C; Pin JP; Hardelin JP; Rondard P
    FASEB J; 2014 Aug; 28(8):3734-44. PubMed ID: 24830383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor.
    Ren XR; Reiter E; Ahn S; Kim J; Chen W; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1448-53. PubMed ID: 15671180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β-Arrestins in the central nervous system.
    Latapy C; Beaulieu JM
    Prog Mol Biol Transl Sci; 2013; 118():267-95. PubMed ID: 23764058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and pharmacological implications of beta-arrestin regulation.
    Schmid CL; Bohn LM
    Pharmacol Ther; 2009 Mar; 121(3):285-93. PubMed ID: 19100766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SnapShot: β-Arrestin Functions.
    Ahn S; Shenoy SK; Luttrell LM; Lefkowitz RJ
    Cell; 2020 Sep; 182(5):1362-1362.e1. PubMed ID: 32888497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.